INTECH Investment Management’s Organogenesis Holdings ORGO Stock Holding History

INTECH Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.1K	Sell	16,099 -1,925	-11%	-$4.7K	﹤0.01%	2077
2026 Q1	$42.7K	Sell	18,024 -9,928	-36%	-$34.4K	﹤0.01%	2024
2025 Q4	$145K	Hold	27,952	–	–	﹤0.01%	2081
2025 Q3	$118K	Sell	27,952 -2,488	-8%	-$11.6K	﹤0.01%	2221
2025 Q2	$111K	Sell	30,440 -18,290	-38%	-$68.2K	﹤0.01%	2270
2025 Q1	$211K	Buy	48,730 +10,723	+28%	+$43.3K	﹤0.01%	2066
2024 Q4	$122K	Buy	38,007 +22,910	+152%	+$76.9K	﹤0.01%	2164
2024 Q3	$43.2K	Buy	+15,097	New	+$42.3K	﹤0.01%	1993

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

INTECH Investment Management's ORGO Position: Q2 2026 in Review

INTECH Investment Management reduced its Organogenesis Holdings (ORGO) stake by 11% in Q2 2026, selling an estimated $4.7K and leaving 16,099 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

INTECH Investment Management first reported a position in ORGO in Q3 2024 and has held it in 8 quarters since. The position peaked at $211K in Q1 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

INTECH Investment Management held 16,099 shares of Organogenesis Holdings worth $39.1K as of Q2 2026.
INTECH Investment Management sold 1,925 Organogenesis Holdings shares in Q2 2026, an estimated $4.7K.
Organogenesis Holdings made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2077 holding.
INTECH Investment Management first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Organogenesis Holdings position peaked at $211K in Q1 2025.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.